SIAXI: Efficacy and safety of incobotulinumtoxinA for the treatment of sialorrhea in Parkinson's disease (PD) and other neurological conditions: results of a Phase III, placebo-controlled, randomised, doubleblind study

J. Csikos, A. Blitzer, A. Friedman, O. Michel, B. Flatau-Baque, W. Jost

Research output: Contribution to journalMeeting abstract (Journal)

Original languageEnglish
Pages (from-to)12-12
JournalInternational Journal of Stroke
Volume13
Publication statusPublished - Dec 2018

Cite this